Comparison of overall survival of lisocabtagene maraleucel (liso‐cel) versus standard of care (SOC) adjusting for crossover in second‐line (2L) R/R large B‐cell lymphoma

Saved in:

Bibliographic Details
Published in	Hematological oncology Vol. 41; no. S2; pp. 451 - 452
Main Authors	Morschhauser, F., Ghesquieres, H., Kamdar, M., Liu, F. F., Chandler, C., Crotta, A., Klijn, S. L., Elsada, A., Previtali, A., Chaillol, I., Proskorovsky, I., Schmitz, N., Gisselbrecht, C., Abramson, J. S.
Format	Journal Article
Language	English
Published	Chichester Wiley Subscription Services, Inc 01.06.2023
Subjects	Lymphoma
Online Access	Get full text

Loading…

More Information
ISSN:	0278-0232 1099-1069
DOI:	10.1002/hon.3164_332